Literature DB >> 11899426

B-cell precursors differentiated from cord blood CD34+ cells are more immature than those derived from granulocyte colony-stimulating factor-mobilized peripheral blood CD34+ cells.

Y Hirose1, H Kiyoi, K Itoh, K Kato, H Saito, T Naoe.   

Abstract

Umbilical cord blood (CB) has been widely used instead of bone marrow (BM) and peripheral blood (PB) for stem cell transplantation (SCT). However, problems of sustained immunodeficiency after CB transplantation remain to be resolved. To elucidate the mechanism of immunodeficiency, we compared the characteristics of B cells differentiated in vitro from CD34+ cells of CB with those of PB. Purified CD34+ cells from CB and PB were cultured on murine stroma cell-line MS-5 with stem cell factor and granulocyte colony-stimulating factor for 6 weeks. The B-cell precursors (pre-B cells) that differentiated in this culture system, were analysed as to their immunoglobulin heavy chain (IgH) variable region gene repertoire and the expression of B-cell differentiation-related genes. CD10+ CD19+ pre-B cells were differentiated from both PB and CB. Although the usages of IgH gene segments in pre-B cells differentiated from CB and PB were similar, the N region was significantly shorter in CB-derived than PB-derived cells. Productive rearrangements were significantly fewer in cells of CB than PB in the third week. Among a number of B-cell differentiation-related genes, the terminal deoxynucleotidyl transferase (TdT) gene was not expressed in CB-derived cells during the culture. These results indicated that immature features of pre-B cells from CB, such as lack of TdT expression, and a short N region and few productive rearrangements in the IgH gene, might cause the delay in mature B-cell production.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11899426      PMCID: PMC1783328          DOI: 10.1046/j.1365-2567.2001.01336.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  51 in total

1.  IgM heavy chain complementarity-determining region 3 diversity is constrained by genetic and somatic mechanisms until two months after birth.

Authors:  S Shiokawa; F Mortari; J O Lima; C Nuñez; F E Bertrand; P M Kirkham; S Zhu; A P Dasanayake; H W Schroeder
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

2.  In vitro reconstitution of human B-cell ontogeny: from CD34(+) multipotent progenitors to Ig-secreting cells.

Authors:  A C Fluckiger; E Sanz; M Garcia-Lloret; T Su; Q L Hao; R Kato; S Quan; A de la Hera; G M Crooks; O N Witte; D J Rawlings
Journal:  Blood       Date:  1998-12-15       Impact factor: 22.113

Review 3.  Does cord blood transplantation result in lower graft-versus-host disease? It takes more than two to tango.

Authors:  J A Madrigal; S B Cohen; E Gluckman; D J Charron
Journal:  Hum Immunol       Date:  1997 Aug-Sep       Impact factor: 2.850

4.  Culture system for extensive production of CD19+IgM+ cells by human cord blood CD34+ progenitors.

Authors:  J I Ohkawara; K Ikebuchi; M Fujihara; N Sato; F Hirayama; M Yamaguchi; K J Mori; S Sekiguchi
Journal:  Leukemia       Date:  1998-05       Impact factor: 11.528

5.  The umbilical cord blood alphabeta T-cell repertoire: characteristics of a polyclonal and naive but completely formed repertoire.

Authors:  L Garderet; N Dulphy; C Douay; N Chalumeau; V Schaeffer; M T Zilber; A Lim; J Even; N Mooney; C Gelin; E Gluckman; D Charron; A Toubert
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

6.  Outcomes among 562 recipients of placental-blood transplants from unrelated donors.

Authors:  P Rubinstein; C Carrier; A Scaradavou; J Kurtzberg; J Adamson; A R Migliaccio; R L Berkowitz; M Cabbad; N L Dobrila; P E Taylor; R E Rosenfield; C E Stevens
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

7.  Graft-versus-host disease and graft-versus-leukemia effect in mice grafted with peripheral newborn blood.

Authors:  V de La Selle; E Gluckman; M Bruley-Rosset
Journal:  Blood       Date:  1998-11-15       Impact factor: 22.113

8.  Sequence homologies, N sequence insertion and JH gene utilization in VHDJH joining: implications for the joining mechanism and the ontogenetic timing of Ly1 B cell and B-CLL progenitor generation.

Authors:  H Gu; I Förster; K Rajewsky
Journal:  EMBO J       Date:  1990-07       Impact factor: 11.598

9.  Early human IgH gene assembly in Epstein-Barr virus-transformed fetal B cell lines. Preferential utilization of the most JH-proximal D segment (DQ52) and two unusual VH-related rearrangements.

Authors:  K G Nickerson; J Berman; E Glickman; L Chess; F W Alt
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

10.  The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus.

Authors:  F Matsuda; K Ishii; P Bourvagnet; K i Kuma; H Hayashida; T Miyata; T Honjo
Journal:  J Exp Med       Date:  1998-12-07       Impact factor: 14.307

View more
  7 in total

1.  BMI-1 is highly expressed in M0-subtype acute myeloid leukemia.

Authors:  Masashi Sawa; Kazuhito Yamamoto; Toshiya Yokozawa; Hitoshi Kiyoi; Asahi Hishida; Tomohiro Kajiguchi; Masao Seto; Akio Kohno; Kunio Kitamura; Yoshie Itoh; Norio Asou; Nobuyuki Hamajima; Nobuhiko Emi; Tomoki Naoe
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

Review 2.  Mankind's first natural stem cell transplant.

Authors:  Jose N Tolosa; Dong-Hyuk Park; David J Eve; Stephen K Klasko; Cesario V Borlongan; Paul R Sanberg
Journal:  J Cell Mol Med       Date:  2010-02-05       Impact factor: 5.310

3.  Personalized Radioproteomics: Identification of a Protein Biomarker Signature for Preemptive Rescue by Tocopherol Succinate in CD34+ Irradiated Progenitor Cells Isolated from a Healthy Control Donor.

Authors:  Anjali Srivastava; Ximena Leighton; Ofer Eidelman; Joshua Starr; Catherine Jozwik; Meera Srivastava; Harvey B Pollard; Vijay K Singh
Journal:  J Proteomics Bioinform       Date:  2015-01-28

4.  Downregulation of Endothelin Receptor B Contributes to Defective B Cell Lymphopoiesis in Trisomy 21 Pluripotent Stem Cells.

Authors:  Glenn A MacLean; Jennifer McEldoon; Jialiang Huang; Jeremy Allred; Matthew C Canver; Stuart H Orkin
Journal:  Sci Rep       Date:  2018-05-22       Impact factor: 4.379

5.  Chromosomal translocation t(11;14) and p53 deletion induced by the CRISPR/Cas9 system in normal B cell-derived iPS cells.

Authors:  Yusuke Azami; Naohiro Tsuyama; Yu Abe; Misaki Sugai-Takahashi; Ken-Ichi Kudo; Akinobu Ota; Karnan Sivasundaram; Moe Muramatsu; Tomonari Shigemura; Megumi Sasatani; Yuko Hashimoto; Shigehira Saji; Kenji Kamiya; Ichiro Hanamura; Takayuki Ikezoe; Masafumi Onodera; Akira Sakai
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

6.  Regeneration of immunocompetent B lymphopoiesis from pluripotent stem cells guided by transcription factors.

Authors:  Qi Zhang; Bingyan Wu; Qitong Weng; Fangxiao Hu; Yunqing Lin; Chengxiang Xia; Huan Peng; Yao Wang; Xiaofei Liu; Lijuan Liu; Jiapin Xiong; Yang Geng; Yalan Zhao; Mengyun Zhang; Juan Du; Jinyong Wang
Journal:  Cell Mol Immunol       Date:  2021-12-10       Impact factor: 22.096

Review 7.  Polyomavirus JC in the context of immunosuppression: a series of adaptive, DNA replication-driven recombination events in the development of progressive multifocal leukoencephalopathy.

Authors:  Edward M Johnson; Margaret J Wortman; Ayuna V Dagdanova; Patric S Lundberg; Dianne C Daniel
Journal:  Clin Dev Immunol       Date:  2013-04-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.